Concepts (196)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Non-alcoholic Fatty Liver Disease | 4 | 2021 | 421 | 1.440 |
Why?
|
| Apolipoproteins B | 5 | 2010 | 106 | 0.990 |
Why?
|
| Lipoproteins, VLDL | 5 | 2018 | 89 | 0.880 |
Why?
|
| Liver Cirrhosis | 5 | 2019 | 941 | 0.860 |
Why?
|
| Fatty Liver | 1 | 2021 | 235 | 0.700 |
Why?
|
| Elasticity Imaging Techniques | 1 | 2021 | 171 | 0.670 |
Why?
|
| Lipase | 1 | 2018 | 112 | 0.620 |
Why?
|
| Lipoproteins | 1 | 2019 | 252 | 0.610 |
Why?
|
| Aspartate Aminotransferases | 1 | 2014 | 153 | 0.470 |
Why?
|
| Models, Molecular | 5 | 2010 | 1732 | 0.470 |
Why?
|
| Colectomy | 1 | 2015 | 288 | 0.460 |
Why?
|
| Liver Diseases | 1 | 2019 | 574 | 0.460 |
Why?
|
| Alanine Transaminase | 1 | 2014 | 227 | 0.450 |
Why?
|
| Colitis, Ulcerative | 1 | 2015 | 268 | 0.430 |
Why?
|
| Cholesterol, HDL | 1 | 2014 | 341 | 0.430 |
Why?
|
| Patient Readmission | 1 | 2015 | 548 | 0.390 |
Why?
|
| Cholesterol, LDL | 1 | 2014 | 565 | 0.360 |
Why?
|
| Apyrase | 3 | 2019 | 44 | 0.350 |
Why?
|
| Egg Proteins, Dietary | 2 | 2006 | 4 | 0.340 |
Why?
|
| Blood Proteins | 2 | 2009 | 294 | 0.320 |
Why?
|
| Membrane Proteins | 1 | 2018 | 2819 | 0.300 |
Why?
|
| Microfilament Proteins | 3 | 2009 | 487 | 0.300 |
Why?
|
| Cholangitis, Sclerosing | 2 | 2019 | 77 | 0.300 |
Why?
|
| Keratin-18 | 2 | 2016 | 10 | 0.280 |
Why?
|
| Protein Structure, Tertiary | 8 | 2010 | 1487 | 0.280 |
Why?
|
| Lipoproteins, LDL | 3 | 2018 | 163 | 0.270 |
Why?
|
| Trypsin | 1 | 2005 | 140 | 0.260 |
Why?
|
| Antigens, CD | 3 | 2019 | 1385 | 0.240 |
Why?
|
| Phosphoproteins | 2 | 2009 | 1152 | 0.240 |
Why?
|
| Egg Proteins | 3 | 2010 | 66 | 0.230 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2005 | 997 | 0.230 |
Why?
|
| Nutrition Surveys | 2 | 2021 | 295 | 0.210 |
Why?
|
| Pancreatitis | 1 | 2023 | 267 | 0.190 |
Why?
|
| Mutation, Missense | 3 | 2011 | 1152 | 0.180 |
Why?
|
| Multivariate Analysis | 3 | 2016 | 4298 | 0.180 |
Why?
|
| Triglycerides | 3 | 2011 | 603 | 0.180 |
Why?
|
| Protein Structure, Secondary | 4 | 2010 | 336 | 0.170 |
Why?
|
| Alcohol Drinking | 1 | 2021 | 551 | 0.160 |
Why?
|
| Protein Folding | 3 | 2009 | 281 | 0.150 |
Why?
|
| Lipoproteins, HDL | 1 | 2018 | 144 | 0.150 |
Why?
|
| Defecation | 1 | 2017 | 58 | 0.150 |
Why?
|
| United States | 4 | 2021 | 15433 | 0.150 |
Why?
|
| Circular Dichroism | 2 | 2007 | 113 | 0.140 |
Why?
|
| Portasystemic Shunt, Transjugular Intrahepatic | 1 | 2016 | 27 | 0.140 |
Why?
|
| Hepatitis, Autoimmune | 1 | 2016 | 51 | 0.140 |
Why?
|
| ROC Curve | 2 | 2016 | 1183 | 0.130 |
Why?
|
| Purines | 1 | 2017 | 273 | 0.130 |
Why?
|
| Colonoscopy | 1 | 2019 | 518 | 0.130 |
Why?
|
| Ileostomy | 1 | 2015 | 46 | 0.130 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2018 | 624 | 0.130 |
Why?
|
| Ascites | 1 | 2016 | 198 | 0.130 |
Why?
|
| Th17 Cells | 1 | 2016 | 162 | 0.130 |
Why?
|
| Adenoma | 1 | 2019 | 716 | 0.120 |
Why?
|
| Humans | 21 | 2023 | 261506 | 0.120 |
Why?
|
| Feces | 1 | 2017 | 770 | 0.120 |
Why?
|
| Anastomosis, Surgical | 1 | 2015 | 371 | 0.120 |
Why?
|
| Steroids | 1 | 2015 | 356 | 0.120 |
Why?
|
| Adult | 7 | 2021 | 77950 | 0.110 |
Why?
|
| Linear Models | 1 | 2016 | 1085 | 0.110 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 3 | 2009 | 71 | 0.110 |
Why?
|
| Activities of Daily Living | 1 | 2016 | 552 | 0.110 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2017 | 363 | 0.110 |
Why?
|
| Middle Aged | 8 | 2019 | 86204 | 0.110 |
Why?
|
| Prospective Studies | 2 | 2018 | 12873 | 0.100 |
Why?
|
| Treatment Failure | 1 | 2015 | 1391 | 0.100 |
Why?
|
| Length of Stay | 2 | 2016 | 1900 | 0.100 |
Why?
|
| Apolipoprotein C-III | 1 | 2011 | 31 | 0.100 |
Why?
|
| Apolipoproteins C | 1 | 2010 | 8 | 0.090 |
Why?
|
| Lipid Metabolism Disorders | 1 | 2010 | 5 | 0.090 |
Why?
|
| Odds Ratio | 1 | 2015 | 2316 | 0.090 |
Why?
|
| Cardiovascular Diseases | 1 | 2023 | 2195 | 0.090 |
Why?
|
| Male | 9 | 2019 | 123000 | 0.090 |
Why?
|
| Models, Chemical | 2 | 2007 | 186 | 0.090 |
Why?
|
| Genotype | 1 | 2018 | 4109 | 0.090 |
Why?
|
| Heart Failure | 1 | 2023 | 2516 | 0.090 |
Why?
|
| Female | 9 | 2019 | 141928 | 0.080 |
Why?
|
| Obesity | 1 | 2021 | 2884 | 0.080 |
Why?
|
| Registries | 1 | 2016 | 2170 | 0.080 |
Why?
|
| Hypobetalipoproteinemias | 1 | 2007 | 2 | 0.080 |
Why?
|
| Actins | 2 | 2009 | 608 | 0.080 |
Why?
|
| Apolipoprotein B-100 | 1 | 2007 | 30 | 0.080 |
Why?
|
| Gelsolin | 1 | 2007 | 14 | 0.080 |
Why?
|
| Dimyristoylphosphatidylcholine | 1 | 2007 | 16 | 0.080 |
Why?
|
| Kinetics | 2 | 2010 | 2049 | 0.080 |
Why?
|
| Chylomicrons | 1 | 2006 | 9 | 0.070 |
Why?
|
| Protein Binding | 3 | 2010 | 3438 | 0.070 |
Why?
|
| Phosphatidylcholines | 1 | 2006 | 144 | 0.070 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2018 | 4549 | 0.070 |
Why?
|
| Liver | 1 | 2015 | 2961 | 0.070 |
Why?
|
| Time Factors | 2 | 2019 | 12926 | 0.070 |
Why?
|
| Severity of Illness Index | 1 | 2016 | 4320 | 0.070 |
Why?
|
| Escherichia coli | 3 | 2009 | 1203 | 0.070 |
Why?
|
| Motion | 1 | 2006 | 193 | 0.070 |
Why?
|
| Spodoptera | 1 | 2005 | 63 | 0.070 |
Why?
|
| Endoplasmic Reticulum | 1 | 2006 | 308 | 0.060 |
Why?
|
| Biophysics | 1 | 2005 | 111 | 0.060 |
Why?
|
| Fimbriae, Bacterial | 1 | 2004 | 66 | 0.060 |
Why?
|
| Hydrolysis | 1 | 2005 | 227 | 0.060 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2006 | 611 | 0.060 |
Why?
|
| Disease Progression | 1 | 2016 | 6682 | 0.060 |
Why?
|
| Cross-Linking Reagents | 1 | 2005 | 153 | 0.060 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2018 | 5539 | 0.060 |
Why?
|
| Bacterial Adhesion | 1 | 2004 | 147 | 0.060 |
Why?
|
| Colorectal Neoplasms | 1 | 2019 | 3578 | 0.060 |
Why?
|
| Cross-Sectional Studies | 1 | 2014 | 4314 | 0.060 |
Why?
|
| Animals | 5 | 2019 | 59536 | 0.060 |
Why?
|
| Ketone Bodies | 1 | 2023 | 56 | 0.060 |
Why?
|
| Biomarkers | 3 | 2023 | 5047 | 0.060 |
Why?
|
| Acetylation | 1 | 2023 | 508 | 0.050 |
Why?
|
| Carrier Proteins | 2 | 2010 | 2022 | 0.050 |
Why?
|
| Macrophages | 2 | 2019 | 1304 | 0.050 |
Why?
|
| Calcium | 1 | 2007 | 1537 | 0.050 |
Why?
|
| Postoperative Complications | 1 | 2015 | 5542 | 0.050 |
Why?
|
| Glycoproteins | 1 | 2023 | 747 | 0.040 |
Why?
|
| Retrospective Studies | 3 | 2019 | 37905 | 0.040 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2023 | 803 | 0.040 |
Why?
|
| Aged | 3 | 2023 | 70117 | 0.040 |
Why?
|
| Peptide Fragments | 1 | 2005 | 1271 | 0.040 |
Why?
|
| Signal Transduction | 1 | 2017 | 11965 | 0.040 |
Why?
|
| Atherosclerosis | 1 | 2006 | 935 | 0.040 |
Why?
|
| Acute Disease | 1 | 2023 | 2422 | 0.040 |
Why?
|
| Phosphorylation | 1 | 2006 | 4804 | 0.040 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2016 | 3639 | 0.040 |
Why?
|
| Dietary Fiber | 1 | 2017 | 123 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2023 | 2803 | 0.040 |
Why?
|
| Receptor, Adenosine A2A | 1 | 2016 | 27 | 0.040 |
Why?
|
| Income | 1 | 2017 | 222 | 0.040 |
Why?
|
| Receptors, Aryl Hydrocarbon | 1 | 2017 | 85 | 0.040 |
Why?
|
| Fecal Microbiota Transplantation | 1 | 2017 | 149 | 0.030 |
Why?
|
| Adenosine Deaminase | 1 | 2016 | 94 | 0.030 |
Why?
|
| Phosphoric Diester Hydrolases | 1 | 2016 | 103 | 0.030 |
Why?
|
| Dysbiosis | 1 | 2017 | 134 | 0.030 |
Why?
|
| Educational Status | 1 | 2017 | 397 | 0.030 |
Why?
|
| Reagent Kits, Diagnostic | 1 | 2015 | 70 | 0.030 |
Why?
|
| Reference Values | 1 | 2017 | 1099 | 0.030 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2017 | 376 | 0.030 |
Why?
|
| Adenosine | 1 | 2017 | 289 | 0.030 |
Why?
|
| Aging | 1 | 2023 | 1582 | 0.030 |
Why?
|
| Disability Evaluation | 1 | 2016 | 249 | 0.030 |
Why?
|
| Interleukin-17 | 1 | 2016 | 250 | 0.030 |
Why?
|
| Exosomes | 1 | 2017 | 253 | 0.030 |
Why?
|
| Area Under Curve | 1 | 2015 | 700 | 0.030 |
Why?
|
| Inflammation | 1 | 2023 | 2522 | 0.030 |
Why?
|
| Binding Sites | 2 | 2010 | 2171 | 0.030 |
Why?
|
| Incidence | 1 | 2023 | 5673 | 0.030 |
Why?
|
| Image-Guided Biopsy | 1 | 2015 | 327 | 0.030 |
Why?
|
| Follow-Up Studies | 2 | 2019 | 14889 | 0.030 |
Why?
|
| Regression Analysis | 1 | 2016 | 1546 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2015 | 1489 | 0.030 |
Why?
|
| Pyridines | 1 | 2019 | 1244 | 0.030 |
Why?
|
| Lymphocytes | 1 | 2017 | 1234 | 0.030 |
Why?
|
| Sex Factors | 1 | 2017 | 2139 | 0.030 |
Why?
|
| Amino Acid Sequence | 2 | 2009 | 4233 | 0.030 |
Why?
|
| Chromatography, Gel | 1 | 2011 | 157 | 0.030 |
Why?
|
| Subcellular Fractions | 1 | 2011 | 201 | 0.020 |
Why?
|
| Microsomes, Liver | 1 | 2011 | 115 | 0.020 |
Why?
|
| Molecular Sequence Data | 2 | 2009 | 6089 | 0.020 |
Why?
|
| Lipoproteins, IDL | 1 | 2010 | 5 | 0.020 |
Why?
|
| Brefeldin A | 1 | 2010 | 22 | 0.020 |
Why?
|
| Microsomes | 1 | 2010 | 61 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2016 | 3536 | 0.020 |
Why?
|
| Chickens | 1 | 2010 | 523 | 0.020 |
Why?
|
| Threonine | 1 | 2010 | 161 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2016 | 3033 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2019 | 5710 | 0.020 |
Why?
|
| Alanine | 1 | 2010 | 240 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 1 | 2019 | 2403 | 0.020 |
Why?
|
| Surface Plasmon Resonance | 1 | 2009 | 105 | 0.020 |
Why?
|
| Ultrasonography | 1 | 2015 | 1863 | 0.020 |
Why?
|
| Actin Cytoskeleton | 1 | 2009 | 82 | 0.020 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2011 | 368 | 0.020 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2017 | 907 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2019 | 6942 | 0.020 |
Why?
|
| Young Adult | 2 | 2017 | 21445 | 0.020 |
Why?
|
| Gene Expression | 1 | 2016 | 3570 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2015 | 4988 | 0.020 |
Why?
|
| Hospitalization | 1 | 2016 | 2083 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2019 | 7222 | 0.020 |
Why?
|
| Family Health | 1 | 2007 | 325 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2015 | 6009 | 0.020 |
Why?
|
| Fimbriae Proteins | 1 | 2004 | 34 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2016 | 7548 | 0.020 |
Why?
|
| Microscopy, Electron | 1 | 2004 | 600 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2016 | 7226 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2009 | 2927 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2016 | 9244 | 0.010 |
Why?
|
| Risk Factors | 1 | 2019 | 17523 | 0.010 |
Why?
|
| Escherichia coli Proteins | 1 | 2004 | 359 | 0.010 |
Why?
|
| Cell Line | 1 | 2010 | 5114 | 0.010 |
Why?
|
| Infant | 1 | 2016 | 13310 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2016 | 16273 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2010 | 4053 | 0.010 |
Why?
|
| Mice | 1 | 2019 | 34495 | 0.010 |
Why?
|
| Adolescent | 1 | 2016 | 31252 | 0.010 |
Why?
|
| Child | 1 | 2016 | 29154 | 0.010 |
Why?
|
| Mutation | 1 | 2004 | 15179 | 0.000 |
Why?
|